Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE733.8021.6 (+3.03 % )
PREV CLOSE (Rs.) 712.20
OPEN PRICE (Rs.) 718.25
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 66504
TODAY'S LOW / HIGH (Rs.)714.10 744.25
52 WK LOW / HIGH (Rs.)155.5 1025
NSE733.50 21.2 (+2.98 % )
PREV CLOSE(Rs.) 712.30
OPEN PRICE (Rs.) 714.00
BID PRICE (QTY) 733.50 (186 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1534378
TODAY'S LOW / HIGH(Rs.) 713.90 745.00
52 WK LOW / HIGH (Rs.)137.5 1026.95

Board Meetings

Source Date Board Meeting Date Details
16-Mar-2021 19-Mar-2021 Buy Back of Shares
19-Jan-2021 25-Jan-2021 Quarterly Results
20-Oct-2020 23-Oct-2020 Interim Dividend & Audited Results
19-Oct-2020 23-Oct-2020 Audited Results
17-Aug-2020 20-Aug-2020 Bonus issue
11-May-2020 15-May-2020 Audited Results
29-Jan-2020 06-Feb-2020 Interim Dividend & Quarterly Results
11-Oct-2019 23-Oct-2019 AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2019 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2019.
17-Jul-2019 26-Jul-2019 Quarterly Results
07-May-2019 15-May-2019 AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2019 ,inter alia, to consider and approve This is to inform you that the next meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, May 15, 2019 inter-alia to; 1) Consider, approve and take on record Audited Financial Results for the quarter and year ended March 31, 2019. 2) Consider and recommend final dividend, if any, for the year ended March 31, 2019.